Affiliation:
1. Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46206
Abstract
The antimicrobial activity of cinoxacin, 1-ethyl-4(1H)-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid, previously reported as compound 64716, was determined and compared with other antimicrobial agents at a dosage of 12 mg/kg once daily in a descending pyelonephritis rat model with
Escherichia coli
and
Proteus mirabilis
as infecting organisms. Cinoxacin was considerably more effective than either nalidixic acid or oxolinic acid when all three were administered orally at 3 mg/kg four times daily. The presence of demonstrable serum activity with a high recovery in urine indicates cinoxacin possesses highly desirable properties of an effective oral chemotherapeutic agent for urinary tract infections.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference5 articles.
1. Ion pair extraction and high-speed liquid chromatography of cephalothin and deacetylcephalothin in human serum and urine;Cooper M. J.;Drug Metab. Disposition,1973
2. Activity of tetracyclines, nalidixic acids, and nitrofurantoin in two experimental models of Escherichia coli urinary tract disease in rats;English A. R.;Proc. Soc. Exp. Biol. Med.,1971
3. Carbenicillin indanyl sodium, an orally active derivative of carbenicillin;English A. R.;Antimicrob. Ag. Chemother.,1972
4. Experimental pyelonephritis. 1. Effect of ureteral ligation on the course of bacterial infection in the kidney of the rat;Guze L. B.;J. Exp. Med.,1956
5. Compound 64716, a new synthetic antibacterial agent;Wick W. E.;Antimicrob. Ag. Chemother.,1973
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献